Neena M. Patil's most recent trade in Jazz Pharmaceuticals plc was a trade of 27,084 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 27,084 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 137.12 per share. | 26 Feb 2026 | 27,084 | 83,946 (0%) | 0% | 137.1 | 3,713,758 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 20,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.10 per share. | 26 Feb 2026 | 20,125 | 73,464 (0%) | 0% | 113.1 | 2,276,138 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 192.53 per share. | 26 Feb 2026 | 16,602 | 56,862 (0%) | 0% | 192.5 | 3,196,335 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 190.28 per share. | 26 Feb 2026 | 15,555 | 68,391 (0%) | 0% | 190.3 | 2,959,807 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 191.65 per share. | 26 Feb 2026 | 11,529 | 66,941 (0%) | 0% | 191.6 | 2,209,481 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 10,079 | 78,470 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 193.58 per share. | 26 Feb 2026 | 3,523 | 63,418 (0%) | 0% | 193.6 | 681,993 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 137.12 per share. | 26 Feb 2026 | 2,916 | 71,307 (0%) | 0% | 137.1 | 399,842 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 189.81 per share. | 26 Feb 2026 | 2,916 | 68,391 (0%) | 0% | 189.8 | 553,491 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 2,916 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 191.88 per share. | 26 Feb 2026 | 1,784 | 60,024 (0%) | 0% | 191.9 | 342,312 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 190.00 per share. | 26 Feb 2026 | 1,061 | 62,357 (0%) | 0% | 190.0 | 201,594 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 192.79 per share. | 26 Feb 2026 | 1,009 | 59,015 (0%) | 0% | 192.8 | 194,527 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 192.07 per share. | 26 Feb 2026 | 875 | 56,862 (0%) | 0% | 192.1 | 168,057 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2026 | 875 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.10 per share. | 26 Feb 2026 | 875 | 57,737 (0%) | 0% | 113.1 | 98,963 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 190.80 per share. | 26 Feb 2026 | 549 | 61,808 (0%) | 0% | 190.8 | 104,747 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 193.60 per share. | 26 Feb 2026 | 197 | 58,818 (0%) | 0% | 193.6 | 38,139 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 8,852 | 56,614 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale or transfer of securities back to the company at price $ 171.16 per share. | 16 Jan 2026 | 3,275 | 53,339 (0%) | 0% | 171.2 | 560,549 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 2,226 | 2,226 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,051 | 2,626 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale or transfer of securities back to the company at price $ 138.95 per share. | 05 Mar 2025 | 4,088 | 47,526 (0%) | 0% | 139.0 | 568,028 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 12,518 | 45,836 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 5,778 | 51,614 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.87 per share. | 27 Feb 2025 | 3,800 | 33,318 (0%) | 0% | 144.9 | 550,506 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 5,864 | 39,023 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.62 per share. | 17 Jan 2025 | 1,905 | 37,118 (0%) | 0% | 122.6 | 233,591 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 123.41 per share. | 08 Nov 2024 | 3,700 | 33,048 (0%) | 0% | 123.4 | 456,617 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,349 | 1,349 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 649 | 1,575 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 109.65 per share. | 03 May 2024 | 5,000 | 36,629 (0%) | 0% | 109.7 | 548,250 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.53 per share. | 05 Mar 2024 | 3,432 | 41,629 (0%) | 0% | 117.5 | 403,363 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,348 | 45,061 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena Patil M. | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 5,087 | 34,369 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patil Neena M. | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 119.13 per share. | 17 Jan 2024 | 1,656 | 32,713 (0%) | 0% | 119.1 | 197,279 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 139.59 per share. | 15 Aug 2023 | 750 | 30,686 (0%) | 0% | 139.6 | 104,695 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale or transfer of securities back to the company at price $ 131.51 per share. | 07 Aug 2023 | 1,390 | 31,436 (0%) | 0% | 131.5 | 182,799 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 127.98 per share. | 01 Jun 2023 | 1,526 | 32,900 (0%) | 0% | 128.0 | 195,290 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 128.01 per share. | 01 Jun 2023 | 74 | 32,826 (0%) | 0% | 128.0 | 9,473 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 1,076 | 1,076 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 527 | 926 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 9,419 | 36,262 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.78 per share. | 03 Mar 2023 | 1,923 | 34,339 (0%) | 0% | 142.8 | 274,566 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.34 per share. | 16 Nov 2022 | 3,510 | 26,769 (0%) | 0% | 142.3 | 499,613 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | EVP and Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.72 per share. | 05 Aug 2022 | 1,321 | 30,279 (0%) | 0% | 153.7 | 203,064 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | Chief Legal Officer (CLO) | Sale of securities on an exchange or to another person at price $ 152.15 per share. | 10 May 2022 | 1,000 | 31,600 (0%) | 0% | 152.2 | 152,150 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | Chief Legal Officer (CLO) | Gift of securities by or to the insider at price $ 0.00 per share. | 10 May 2022 | 161 | 32,516 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 153.92 per share. | 06 May 2022 | 296 | 32,677 (0%) | 0% | 153.9 | 45,559 | Ordinary Shares |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,937 | 1,937 | - | - | Stock Option / (Right to Buy) | |
| Teleflex Incorporated | Neena M. Patil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 399 | 399 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharma PLC | Neena M. Patil | Chief Legal Officer (CLO) and | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 8,886 | 34,201 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Neena M. Patil | Chief Legal Officer (CLO) and | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.96 per share. | 03 Mar 2022 | 1,228 | 32,973 (0%) | 0% | 154.0 | 189,063 | Ordinary Shares |
| Jazz Pharma PLC | Neena M. Patil | CLO&SVP Legal and Corp Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.49 per share. | 05 Aug 2021 | 993 | 25,233 (0%) | 0% | 148.5 | 147,451 | Ordinary Shares |